论文部分内容阅读
目的：评价尼莫通（ 尼莫地平） 治疗血管性痴呆的疗效。方法：随机将７４ 例血管性痴呆患者分两组，选复方丹参为对照药，应用韦氏成人智力量表将上两组分为三亚组：８０ ～８９ 分组，７０ ～７９ 分组和７０ 分以下组。结果：尼莫通治疗前后 Ｗ Ａ Ｉ Ｓ Ｒ Ｃ 评分与对照组比较，８０ ～８９ 分组有显著统计学差异， Ｐ＜ ０ ．０１ ，７０ ～７９ 分组有统计学差异， Ｐ＜ ０ ．０５ ，７０ 分以下组无统计学差异， Ｐ＞ ０ ．０５ 。结论：尼莫通对血管性痴呆有较好的治疗作用，且与痴呆程度有关。
PURPOSE: To evaluate the efficacy of nimodipine in the treatment of vascular dementia. Methods: 74 patients with vascular dementia were randomly divided into two groups, the choice of compound Salvia as the control drug, the use of Webster adult intelligence scale the two groups were divided into Sanya group: 80-89 group, 70-79 group and 70 points or less group. Results: Compared with control group, W A I S-R C score before and after nimotop in treatment group showed significant difference (P <0). 01, 70 ~ 79 groups were statistically significant, P <0. There was no significant difference between the groups of 05 and 70 points, P> 0. 05. Conclusion: Nimotong has a good therapeutic effect on vascular dementia and is related to the degree of dementia.